Exhibit 10.73

 

Aethlon Medical, Inc.

2012 Non-Employee Directors Compensation Program

as Modified on August 9, 2016

 

On August 9, 2016, the Compensation Committee of the Board of Directors (the
“Board”) of Aethlon Medical, Inc. (the “Company”) recommended to the Board that
the Company’s 2012 Non-Employee Directors Compensation Program be modified in
its entirety as follows:

 

A.Restricted Stock Units/Stock Options

 

1.New Eligible Directors: A new eligible director will receive an initial grant
of $50,000 worth of restricted stock units or, at the discretion of the Board,
options to acquire shares of common stock. Restricted stock units granted under
this provision will be valued based on the average of the closing prices of the
common stock for the five trading days preceding and including the date of grant
and will vest at a rate determined by the Board in its discretion. Options
granted under this provision will be valued at the exercise price, which will be
based on the average of the closing prices of the common stock for the five
trading days preceding and including the date of grant. Such options will have a
term of ten years and will vest at a rate determined by the Board in its
discretion.

 

2.Existing Eligible Directors: At the beginning of each fiscal year, each
existing eligible director will receive a grant of $35,000 worth of restricted
stock units or, at the discretion of the Board, options to acquire shares of
common stock. Restricted stock units granted under this provision will be valued
based on the average of the closing prices of the common stock for the five
trading days preceding and including the first day of the fiscal year (or
preceding and including the date of grant, if such grant is not made on the
first day of the fiscal year) and will vest at a rate determined by the Board in
its discretion. Options granted under this provision will be valued at the
exercise price, which will be based on the average of the closing prices of the
common stock for the five trading days preceding and including the first day of
the fiscal year (or preceding and including the date of grant, if such grant is
not made on the first day of the fiscal year). Such options will have a term of
ten years and will vest at a rate determined by the Board in its discretion.

 

B.Compensation

 

1.Eligible Director Annual Retainer: Eligible directors will receive an annual
board retainer fee of $30,000.

 

2.Audit Committee Annual Retainer: Each member of the Audit Committee will
receive an annual retainer fee of $4,000, except for the Chair of the Audit
Committee, who will receive an annual retainer of $5,000.

 

3.Compensation Committee Annual Retainer: Each member of the Compensation
Committee will receive an annual retainer fee of $4,000, except for the Chair of
the Compensation Committee, who will receive an annual retainer of $5,000.

 

4.Lead Independent Director: The Lead Independent Director will receive an
annual retainer of $15,000.

 

The Board unanimously approved the Compensation Committee’s recommendation with
the eligible directors abstaining.

 

 

 

 1 

 

 

Aethlon Medical, Inc.

2012 Non-Employee Directors Compensation Program

as Modified on June 5, 2014

 

On June 5, 2014, the Compensation Committee of the Board of Directors (the
“Board”) of Aethlon Medical, Inc. (the “Company”) recommended to the Board that
the Company’s 2012 Non-Employee Directors Compensation Program be modified in
its entirety as follows:

 

A.Stock Options

 

1.New Eligible Directors: A new eligible director will receive an initial grant
of $50,000 worth of options to acquire shares of common stock, with such grant
being valued at the exercise price based on the average of the closing bid
prices of the common stock for the five trading days preceding the first day of
the fiscal year. These options will have a term of ten years and will vest 1/3
upon grant and 1/3 upon each of the first two anniversaries of the date of
grant.

 

2.Existing Eligible Directors: At the beginning of each fiscal year, each
existing eligible director will receive a grant of $35,000 worth of options to
acquire shares of common stock, with such grant being valued at the exercise
price based on the average of the closing bid prices of the common stock for the
five trading days preceding the first day of the fiscal year These options will
have a term of ten years and will vest on the first anniversary of the date of
grant.

 

B.Compensation

 

1.Eligible Director Annual Retainer: Eligible directors will receive an annual
board retainer fee of $30,000.

 

2.Audit Committee Annual Retainer: Each member of the Audit Committee will
receive an annual retainer fee of $4,000, except for the Chair of the Audit
Committee, who will receive an annual retainer of $5,000.

 

3.Compensation Committee Annual Retainer: Each member of the Compensation
Committee will receive an annual retainer fee of $4,000, except for the Chair of
the Compensation Committee, who will receive an annual retainer of $5,000.

 

4.Lead Independent Director: The Lead Independent Director will receive an
annual retainer of $15,000.

 

The Board unanimously approved the Compensation Committee’s recommendation with
the eligible directors abstaining.

 

 

 

 2 

 

 

Aethlon Medical, Inc.

2012 Non-Employee Directors Compensation Program

as Adopted on July 24, 2012

 

On July 24, 2012, the Board of Directors (the “Board”) of Aethlon Medical, Inc.
(the “Company”) adopted the Company’s 2012 Non-Employee Directors Compensation
Program, which modified in its entirety the Company’s 2005 Directors
Compensation Program, as follows:

 

A.Stock Options

 

1.Existing Eligible Directors: At the beginning of each fiscal year, each
existing eligible director will receive a grant of $35,000 worth of options to
acquire shares of common stock, with such grant being valued at the exercise
price based on the average of the closing bid prices of the common stock for the
five trading days preceding the first day of the fiscal year. These options will
have a term of ten years and will vest as follow: $10,000 will vest immediately
upon the date of grant and $20,000 will vest on the first anniversary of the
date of grant contingent upon each eligible director attending not less than 80%
of the Board meetings conducted during the ensuing fiscal year.

 

B.Compensation

 

1.Board Meetings: Eligible directors will receive $1,000 for each Board meeting
attended.

 

2.Committee Meetings: Eligible directors will receive $500 for each Committee
meeting attended.

 

 

 

 

 

 

 

 

 

 

 3